Prevalence of the Factor V E666D Mutation and Its Correlation With Activated Protein C Resistance in the Chinese Population

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical and applied thrombosis/hemostasis

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1076029613514130PMID 24335247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two mechanical methods for thromboembolism prophylaxis after gynaecological pelvic surgery: a prospective, randomised study.

  2012cited by this paper
• Advances in laboratory testing for thrombophilia

  2012influential reference
• Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.

  2012cited by this paper
• Incidence and prevention of venous thromboembolism in acutely ill hospitalized elderly Chinese.

  2011cited by this paper
• A novel mutation (g2172-->c) in the factor V gene in a Chinese family with hereditary activated protein C resistance.

  2010influential reference
• Recent research on venous thromboembolism in China: a brief report from China Venous Thromboembolism Study Group.

  2010cited by this paper
• Activated protein C resistance (APCR) and placental fibrin deposition.

  2008cited by this paper
• Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cited by this paper
• Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

  2006cited by this paper
• An Extremely Low Prevalence of Factor V Leiden, FIIG20210A and FXIIIV34L in Taiwan Chinese Population

  2002cited by this paper
• Factor V Leiden mutation in one family of Chinese origin.

  2001influential reference
• World distribution of factor V Leiden.

  1996cited by this paper
• The Population Genetics of Factor V Leiden (Arg506Gln)

  1996cited by this paper
• World distribution of factor V Leiden.

  1995cited by this paper
• Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.

  1995cited by this paper
• High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

  1995cited by this paper
• Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

  1995cited by this paper
• Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Activated protein C resistance caused by Arg506Gln mutation in factor Va.

  1994cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993influential reference

• Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee.

  2023cites this paper
• Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patients.

  2022cites this paper
• The genetics of venous thromboembolism: a systematic review of thrombophilia families

  2020cites this paper
• Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.

  2020cites this paper
• Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk

  2017cites this paper
• Thrombophilia in Klinefelter Syndrome With Deep Venous Thrombosis, Pulmonary Embolism, and Mesenteric Artery Thrombosis on Testosterone Therapy: A Pilot Study

  2017cites this paper
• Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia

  2016cites this paper